REG - Hikma Pharmaceutical - Director/PDMR Shareholding
10/04/2025 14:45
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250410:nRSJ5612Ea&default-theme=true
RNS Number : 5612E Hikma Pharmaceuticals Plc 10 April 2025
Hikma Pharmaceuticals PLC - Discretionary Share Awards
LONDON, 10 April 2025: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK)
(LEI: 549300BNS685UXH4JI75) announces that the Remuneration Committee made the
following conditional awards under the Hikma Pharmaceuticals PLC 2023 Long
Term Incentive Plan (the "LTIP") and the 2023 Deferred Bonus Plan (the "DBP")
to Persons Discharging Managerial Responsibility ("PDMRs") of the Company. No
consideration was paid for the grant of the awards.
Awards under the LTIP were made on 9 April 2025 based on a price of £18.81
per Ordinary Share (being the average mid-market Ordinary Share price for the
5-working day period prior to 9 April 2025, in accordance with the LTIP rules)
(the "LTIP Awards"). All LTIP Awards are subject to the continued employment
of the PDMR and malus and clawback provisions.
LTIP Performance Share Plan ("PSP") Awards are subject to the satisfaction of
performance conditions set by the Remuneration Committee of the Company. The
LTIP (PSP) Awards will normally vest on the later of the third anniversary of
the date of grant and the determination of the performance conditions. The
LTIP (PSP) Awards are then subject to an additional two-year holding period.
LTIP (Conditional) Awards will normally vest on the second anniversary of the
date of grant.
Awards under the DBP were made on 9 April 2025 based on a price of £18.81 per
Ordinary Share (being the average mid-market Ordinary Share price for the
5-working day period prior to 9 April 2025, in accordance with the DBP rules)
(the "DBP Awards"). The vesting of the DBP Awards is subject to the continued
employment of the PDMRs, and malus and clawback provisions. The DBP Awards
will normally vest on the third anniversary of the date of grant.
This notification is made under Article 19(1) of the EU Market Abuse
Regulation 596/2014 as it forms part of domestic law by virtue of the European
Union (Withdrawal) Act 2018 ("MAR"). The information set out below is provided
in accordance with the requirements of Article 19(3) of MAR.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and DBP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 128,501
Nil DBP Award: 30,783
d) Aggregated information Price(s): Nil
Volume(s): 159,284
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Riad Mishlawi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and DBP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 148,270
Nil DBP Award: 30,582
d) Aggregated information Price(s): Nil
Volume(s): 178,852
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Mazen Darwazah
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP and DBP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 102,554
Nil DBP Award: 25,864
d) Aggregated information Price(s): Nil
Volume(s): 128,418
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Bassam Kanaan
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 73,559
d) Aggregated information Price(s): Nil
Volume(s): 73,559
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 73,620
d) Aggregated information Price(s): Nil
Volume(s): 73,620
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Susan Ringdal
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 38,760
d) Aggregated information Price(s): Nil
Volume(s): 38,760
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Hussein Arkhagha
1 Details of the person discharging managerial responsibilities / person
closely associated
a) Name Hussein Arkhagha
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type
of instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 46,913
d) Aggregated information Price(s): Nil
Volume(s): 46,913
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Bill Larkins
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bill Larkins
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 52,497
d) Aggregated information Price(s): Nil
Volume(s): 52,497
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Julie Hill
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Julie Hill
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 29,501
Nil LTIP (Conditional) Award: 579
d) Aggregated information Price(s): Nil
Volume(s): 30,080
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Hafrun Fridriksdottir
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Hafrun Fridriksdottir
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification Description: Ordinary shares of 10 pence each (Shares)
code
ID Code: GB00B0LCW083
b) Nature of the transaction Grant of awards under the LTIP.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil LTIP (PSP) Award: 57,825
d) Aggregated information Price(s): nil
Volume(s): 57,825
e) Date of the transaction 9 April 2025
f) Place of the transaction Outside a trading venue
Helen Middlemist
Group Company Secretary
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBXGDSSXBDGUGRecent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement